Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,661,482
-$475,711 QoQ
Shares Held
230,572
-24.7% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#199
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $170,891,735 across 22 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
128,626 | $69,693,424 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
297,297 | $50,106,435 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
746,855 | $18,380,101 | |
| 4 | ALKS |
Alkermes plc.
|
109,450 | $5,735,180 | |
| 5 | LQDA |
Liquidia Corp
|
46,133 | $3,678,184 | |
| 6 | VTRS |
Viatris Inc
This page
|
230,572 | $3,661,482 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
80,062 | $3,284,943 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
113,125 | $1,958,193 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,661,482 | 230,572 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,137,193 | 306,232 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $4,710,692 | 378,369 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,511,143 | 354,661 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $6,267,510 | 701,849 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $3,131,497 | 359,529 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $2,052,581 | 164,866 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,228,538 | 191,950 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $938,851 | 88,321 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,085,058 | 90,876 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,000,962 | 92,425 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $892,408 | 90,508 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,080,335 | 1,310,655 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,456,899 | 1,294,896 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $578,036 | 51,935 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $440,654 | 51,720 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $538,650 | 51,447 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $556,501 | 51,149 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $882,345 | 65,214 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $904,611 | 66,761 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $954,572 | 66,800 | Shares | Sole | 2021-09-24 | |
| 2021-03-31 | $11,273,328 | 806,967 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $981,694 | 52,385 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||